2 completed, 1 recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Histrelin Acetate: new trials by email Literature Review of Histrelin Acetate trials Research Report on Histrelin Acetate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 1273 | 2018-09-24 | 2026-10-08 |
| Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer Enzalutamide, leuprolide acetate, goserelin acetate - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Completed | University of Colorado, Denver | 19 | 2015-11-11 | 2025-05-11 |
| Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer histrelin acetate - Prostate Cancer, Adenocarcinoma of the Prostate | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 138 | 2000-04-01 | 2024-01-02 |
Prostatic Neoplasms (3) · Salivary Gland Adenoma, Pleomorphic (1)
Endo USA Inc., a Keenova Therapeutics Company (1) · SWOG Cancer Research Network (1) · University of Colorado, Denver (1)
United States (2) · Chile (1) · Colombia (1) · Mexico (1) · Switzerland (1)
Brian Chapin (1) · Elizabeth Kessler, MD (1) · Regulatory Division (1)
U10CA180888 (1)